Ixazomib (Ninlaro), a proteasome inhibitor, can induce apoptosis in colorectal cancer cells by activating the DR5-mediated death receptor signaling pathway (Yue and Sun, 2019). This evidence concerns the gene TNFRSF10B and colorectal cancer.